Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
24,78 USD | -2,06% | -10,54% | +22,31% |
15/04 | 4D MOLECULAR THERAPEUTICS, INC. : Barclays bevestigt koopadvies | ZM |
15/04 | 4D MOLECULAR THERAPEUTICS, INC. : RBC Capital Markets geeft koopadvies | ZM |
Omzet 2024 * | 6,35 mln. 5,97 mln. | Omzet 2025 * | 7,38 mln. 6,94 mln. | Marktkapitalisatie | 1,29 mld. 1,22 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -151 mln. -142 mln. | Nettowinst (verlies) 2025 * | -164 mln. -154 mln. | EV/omzet 2024 * | 128 x |
Nettoliquiditeiten 2024 * | 480 mln. 451 mln. | Nettoliquiditeiten 2025 * | 319 mln. 299 mln. | EV/omzet 2025 * | 132 x |
K/w-verhouding 2024 * |
-8,12
x | K/w-verhouding 2025 * |
-8,54
x | Werknemers | 147 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,47% |
Recentste transcriptie over 4D Molecular Therapeutics, Inc.
1 dag | -2,06% | ||
1 week | -10,54% | ||
Lopende maand | -22,22% | ||
1 maand | -20,14% | ||
3 maanden | +45,34% | ||
6 maanden | +138,04% | ||
Lopend jaar | +22,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Theresa Janke
FOU | Founder | 49 | 12-09-13 |
David Kirn
FOU | Founder | 62 | 12-09-13 |
Uneek Mehra
DFI | Director of Finance/CFO | - | 12-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 01-08-20 |
Susannah Gray
BRD | Director/Board Member | 63 | 01-07-20 |
Charles Theuer
BRD | Director/Board Member | 60 | 01-01-16 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.74% | 16 M€ | -8,26% | ||
0.06% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 24,78 | -2,06% | 417 554 |
17-04-24 | 25,3 | -5,42% | 519 112 |
16-04-24 | 26,75 | +1,90% | 477 002 |
15-04-24 | 26,25 | -0,38% | 610 526 |
12-04-24 | 26,35 | -4,87% | 401 322 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,31% | 1,29 mld. | |
-1,82% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,56% | 39,61 mld. | |
-12,11% | 25,62 mld. | |
+3,09% | 24,09 mld. | |
-24,16% | 18,38 mld. | |
+22,12% | 11,85 mld. | |
-3,74% | 11,82 mld. | |
+7,75% | 11,07 mld. |